Trizivir Interactions
There are 372 drugs known to interact with Trizivir (abacavir/lamivudine/zidovudine), along with 7 disease interactions, and 5 alcohol/food interactions. Of the total drug interactions, 53 are major, 281 are moderate, and 38 are minor.
- View all 372 medications that may interact with Trizivir
- View Trizivir alcohol/food interactions (5)
- View Trizivir disease interactions (7)
Most frequently checked interactions
View interaction reports for Trizivir (abacavir / lamivudine / zidovudine) and the medicines listed below.
- Aptivus (tipranavir)
- aspirin
- Blincyto (blinatumomab)
- Cerdelga (eliglustat)
- Cipro (ciprofloxacin)
- Corlanor (ivabradine)
- Crestor (rosuvastatin)
- Crixivan (indinavir)
- Cymbalta (duloxetine)
- enalapril
- gabapentin
- Imbruvica (ibrutinib)
- Isentress (raltegravir)
- Kaletra (lopinavir / ritonavir)
- Kalydeco (ivacaftor)
- Keppra (levetiracetam)
- levothyroxine
- lisinopril
- Nexium (esomeprazole)
- Norvir (ritonavir)
- Placidyl (ethchlorvynol)
- Procysbi (cysteamine)
- Prolia (denosumab)
- Ravicti (glycerol phenylbutyrate)
- Remicade (infliximab)
- Ritalin (methylphenidate)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Sustiva (efavirenz)
- Truvada (emtricitabine / tenofovir disoproxil)
Trizivir alcohol/food interactions
There are 5 alcohol/food interactions with Trizivir (abacavir / lamivudine / zidovudine).
Trizivir disease interactions
There are 7 disease interactions with Trizivir (abacavir / lamivudine / zidovudine) which include:
- bone marrow suppression
- myopathy
- hepatitis B
- hepatotoxicity
- pancreatitis
- cardiovascular disease
- renal dysfunction
More about Trizivir (abacavir / lamivudine / zidovudine)
- Trizivir consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.